骨通贴膏联合塞来昔布胶囊治疗膝骨关节炎发作期临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R684.3

基金项目:


Clinical Study on Gutong Plaster Combined with Celecoxib Capsules for Knee Osteoar⁃ thritis at Attack Stage
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察骨通贴膏外用联合塞来昔布胶囊内服治疗膝骨关节炎(KOA) 发作期的临床疗效。方法:将100 例寒湿瘀滞型KOA 发作期患者分为对照组和观察组各50 例。对照组内服塞来昔布胶囊,外用双氯芬酸钠凝胶,观察组服用塞来昔布胶囊,外用骨通贴膏,2 组疗程均为4 周。比较2 组治疗前与治疗7 d、14 d、28 d 的静息时疼痛视觉模拟评分法(VAS) 评分和活动时疼痛VAS 评分,治疗前、治疗4 周后评价疼痛相关症状评分、西安大略和麦马斯特大学骨关节炎指数(WOMAC) 量表评分、寒湿瘀滞证评分和关节炎生活质量测量量表2-短卷(AIMS2-SF) 评分。比较2 组的临床疗效。结果:治疗后,观察组临床疗效优于对照组(P<0.05)。2 组治疗后的静息时VAS 评分与活动时VAS 评分均逐渐降低(P<0.05),观察组治疗7 d、14 d、28 d 的静息时VAS 评分与活动时VAS 评分均低于对照组(P<0.01)。与治疗前相比,2 组疼痛相关症状评分、WOMAC 量表评分及寒湿瘀滞证积分均下降(P<0.01),AIMS2-SF 评分均升高(P<0.01)。观察组疼痛相关症状评分、WOMAC 量表评分及寒湿瘀滞证积分均低于对照组(P<0.01),AIMS2-SF 评分高于对照组(P<0.01)。结论:骨通贴膏外用联合塞来昔布胶囊内服治疗KOA 发作期患者疗效确切,可显著减轻膝关节疼痛,改善膝关节功能,提高患者的生活质量。

    Abstract:

    Abstract: Objective: To observe the clinical effect of the external application of Gutong plaster combined with oral administration of Celecoxib capsules for knee osteoarthritis(KOA) at attack stage. Methods: A total of 100 cases of KOA patients at attack stage of cold-dampness stasis and stagnation type were divided into the control group and the observation group,50 cases in each group. The control group was given the oral administration of Celecoxib capsules and the external application of diclofenac sodium gel. The observation group was given the oral administration of Celecoxib capsules and the external application of Gutong plaster. Both groups were treated for four weeks. Before treatment and on the 7th,14th and 28th days after treatment,in the two groups,the scores of Visual Analogue Scale of pain(VAS) in resting period were compared with those in active period. Before treatment and after four-week treatment,the scores of pain-related symptoms,scores of the Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC) Scale,scores of cold-dampness stasis and stagnation syndrome,and scores of the Arthritis Measurement Scales 2-Short Form(AIMS2-SF) were evaluated. The clinical effect in the two groups was compared. Results: After treatment, the clinical effect in the observation group was better than that in the control group(P<0.05). In the two groups,the VAS scores in resting period and those in active period after treatment were gradually decreased(P<0.05); on the 7th, 14th and 28th days after treatment, the two scores in the observation group were lower than those in the control group(P<0.01). The scores of pain- related symptoms, scores of WOMAC Scale, and scores of cold- dampness stasis and stagnation syndrome in the two groups were decreased when compared with those before treatment(P<0.01),and AIMS2-SF scores were increased(P<0.01). The scores of pain-related symptoms, scores of WOMAC Scale, and scores of cold- dampness stasis and stagnation syndrome in the observation group were lower than those in the control group(P<0.01),and AIMS2-SF score was higher than that in the control group(P< 0.01). Conclusion: The external application of Gutong plaster combined with oral administration of Celecoxib capsules can significantly alleviate the degree of pain in the knee joint and pain- related symptoms of KOA patients at attack stage,and improve function of the knee joint and their quality of life,with defined clinical effect.

    参考文献
    相似文献
    引证文献
引用本文

赵桂琴.骨通贴膏联合塞来昔布胶囊治疗膝骨关节炎发作期临床研究[J].新中医,2020,52(20):84-87

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-10-19
  • 出版日期:
文章二维码